Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Vaccines

Free Subscription Articles published in Proc Natl Acad Sci U S A Retrieve available abstracts of 81 articles: HTML format

Single Articles

December 2021
1. CHU J, Pink SL, Willer R
   Religious identity cues increase vaccination intentions and trust in medical experts among American Christians.
   Proc Natl Acad Sci U S A. 2021;118.
   PubMed     Abstract available
   
   
   November 2021
2. NARR K, Ertuna YI, Fallet B, Cornille K, et al
   Vaccine-elicited CD4 T cells prevent the deletion of antiviral B cells in chronic infection.
   Proc Natl Acad Sci U S A. 2021;118.
   PubMed     Abstract available
   
   
   
3. ADAM D
   News Feature: Biology research, no cells required: By borrowing the machinery of life from broken cells, researchers are producing novel proteins, cheap lab reagents, and just-add-water vaccines.
   Proc Natl Acad Sci U S A. 2021;118.
   PubMed    
   
   
   
4. XIA D, Jin R, Byagathvalli G, Yu H, et al
   An ultra-low-cost electroporator with microneedle electrodes (ePatch) for SARS-CoV-2 vaccination.
   Proc Natl Acad Sci U S A. 2021;118.
   PubMed     Abstract available
   
   
   
5. PISHESHA N, Harmand TJ, Rothlauf PW, Praest P, et al
   A class II MHC-targeted vaccine elicits immunity against SARS-CoV-2 and its variants.
   Proc Natl Acad Sci U S A. 2021;118.
   PubMed     Abstract available
   
   
   October 2021
6. GUTIERREZ-ALVAREZ J, Honrubia JM, Sanz-Bravo A, Gonzalez-Miranda E, et al
   Middle East respiratory syndrome coronavirus vaccine based on a propagation-defective RNA replicon elicited sterilizing immunity in mice.
   Proc Natl Acad Sci U S A. 2021;118.
   PubMed     Abstract available
   
   
   
7. HUGHES MT, Auwaerter PG, Ehmann MR, Garibaldi BT, et al
   Opinion: The importance of offering vaccine choice in the fight against COVID-19.
   Proc Natl Acad Sci U S A. 2021;118.
   PubMed    
   
   
   
8. HENSEN L, Nguyen THO, Rowntree LC, Damelang T, et al
   Robust and prototypical immune responses toward influenza vaccines in the high-risk group of Indigenous Australians.
   Proc Natl Acad Sci U S A. 2021;118.
   PubMed     Abstract available
   
   
   
9. GARCIA-SASTRE A
   Genomics serology to inform therapies and vaccines for arthritogenic alphaviruses.
   Proc Natl Acad Sci U S A. 2021;118.
   PubMed    
   
   
   September 2021
10. CAUDILL C, Perry JL, Iliadis K, Tessema AT, et al
    Transdermal vaccination via 3D-printed microneedles induces potent humoral and cellular immunity.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
11. GOLDMAN E
    How the unvaccinated threaten the vaccinated for COVID-19: A Darwinian perspective.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    
    
    
    
12. KING HAD, Joyce MG, Lakhal-Naouar I, Ahmed A, et al
    Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
13. DUCH R, Roope LSJ, Violato M, Fuentes Becerra M, et al
    Citizens from 13 countries share similar preferences for COVID-19 vaccine allocation priorities.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
14. DALVIE NC, Rodriguez-Aponte SA, Hartwell BL, Tostanoski LH, et al
    Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in mice.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
15. KLUVER H, Hartmann F, Humphreys M, Geissler F, et al
    Incentives can spur COVID-19 vaccination uptake.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    August 2021
16. SILVA PJS, Sagastizabal C, Nonato LG, Struchiner CJ, et al
    Optimized delay of the second COVID-19 vaccine dose reduces ICU admissions.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
17. AGARWAL R, Dugas M, Ramaprasad J, Luo J, et al
    Socioeconomic privilege and political ideology are associated with racial disparity in COVID-19 vaccination.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
18. ASHWORTH M, Thunstrom L, Cherry TL, Newbold SC, et al
    Emphasize personal health benefits to boost COVID-19 vaccination rates.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
19. PINK SL, Chu J, Druckman JN, Rand DG, et al
    Elite party cues increase vaccination intentions among Republicans.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
20. 
    Correction for Madan et al., Mutational fitness landscapes reveal genetic and structural improvement pathways for a vaccine-elicited HIV-1 broadly neutralizing antibody.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    
    
    
    July 2021
21. STAQUICINI DI, Tang FHF, Markosian C, Yao VJ, et al
    Design and proof of concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
22. WANG Y, Yang C, Song Y, Coleman JR, et al
    Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
23. GOLDSTEIN JR, Cassidy T, Wachter KW
    Reply to Dushoff et al. and Pifarre i Arolas et al.: Age prioritization for COVID-19 vaccination does save lives and years of life.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    
    
    
    
24. AROLAS HPI, Acosta E, Myrskyla M
    Optimal vaccination age varies across countries.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    
    
    
    
25. DUSHOFF J, Colijn C, Earn DJD, Bolker BM, et al
    Transmission dynamics are crucial to COVID-19 vaccination policy.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    
    
    
    
26. PETERSEN MB, Bor A, Jorgensen F, Lindholt MF, et al
    Transparent communication about negative features of COVID-19 vaccines decreases acceptance but increases trust.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
27. TSCHERNE A, Schwarz JH, Rohde C, Kupke A, et al
    Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    June 2021
28. SCHMELZ K, Bowles S
    Overcoming COVID-19 vaccination resistance when alternative policies affect the dynamics of conformism, social norms, and crowding out.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
29. SATO-KANEKO F, Yao S, Lao FS, Nan J, et al
    Mitochondria-dependent synthetic small-molecule vaccine adjuvants for influenza virus infection.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
30. MCCARTHY KR, Von Holle TA, Sutherland LL, Oguin TH 3rd, et al
    Differential immune imprinting by influenza virus vaccination and infection in nonhuman primates.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
31. SIA ZR, He X, Zhang A, Ang JC, et al
    A liposome-displayed hemagglutinin vaccine platform protects mice and ferrets from heterologous influenza virus challenge.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    May 2021
32. CHUMAKOV K, Avidan MS, Benn CS, Bertozzi SM, et al
    Old vaccines for new infections: Exploiting innate immunity to control COVID-19 and prevent future pandemics.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
33. MILKMAN KL, Patel MS, Gandhi L, Graci HN, et al
    A megastudy of text-based nudges encouraging patients to get vaccinated at an upcoming doctor's appointment.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
34. DONG C, Wang Y, Gonzalez GX, Ma Y, et al
    Intranasal vaccination with influenza HA/GO-PEI nanoparticles provides immune protection against homo- and heterologous strains.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
35. MAEDA DLNF, Tian D, Yu H, Dar N, et al
    Killed whole-genome reduced-bacteria surface-expressed coronavirus fusion peptide vaccines protect against disease in a porcine model.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    April 2021
36. BUCKNER JH, Chowell G, Springborn MR
    Dynamic prioritization of COVID-19 vaccines when social distancing is limited for essential workers.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
37. CASTRO MC, Singer B
    Prioritizing COVID-19 vaccination by age.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    
    
    
    
38. KORN L, Bohm R, Betsch C
    Reply to Rabb et al.: Why promoting COVID-19 vaccines with community immunity is not a good strategy (yet).
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    
    
    
    March 2021
39. LU EY, Chen HH, Zhao H, Ozawa S, et al
    Health and economic impact of the pneumococcal conjugate vaccine in hindering antimicrobial resistance in China.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
40. BETSCH C, Korn L, Bohm R
    Reply to Weisel: From polarization to vaccination and back.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    
    
    
    
41. WEISEL O
    Vaccination as a social contract: The case of COVID-19 and US political partisanship.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    
    
    
    
42. LE NOUEN C, McCarty T, Yang L, Brown M, et al
    Rescue of codon-pair deoptimized respiratory syncytial virus by the emergence of genomes with very large internal deletions that complemented replication.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
43. LIU R, Americo JL, Cotter CA, Earl PL, et al
    One or two injections of MVA-vectored vaccine shields hACE2 transgenic mice from SARS-CoV-2 upper and lower respiratory tract infection.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
44. LU M, Dravid P, Zhang Y, Trivedi S, et al
    A safe and highly efficacious measles virus-based vaccine expressing SARS-CoV-2 stabilized prefusion spike.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
45. GOLDSTEIN JR, Cassidy T, Wachter KW
    Vaccinating the oldest against COVID-19 saves both the most lives and most years of life.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
46. KAPLAN RM, Milstein A
    Influence of a COVID-19 vaccine's effectiveness and safety profile on vaccination acceptance.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
47. MADAN B, Zhang B, Xu K, Chao CW, et al
    Mutational fitness landscapes reveal genetic and structural improvement pathways for a vaccine-elicited HIV-1 broadly neutralizing antibody.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
48. WU J, Bao C, Reinhardt RL, Abraham SN, et al
    Local induction of bladder Th1 responses to combat urinary tract infections.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
49. CONTI S, Kaczorowski KJ, Song G, Porter K, et al
    Design of immunogens to elicit broadly neutralizing antibodies against HIV targeting the CD4 binding site.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    February 2021
50. FREYN AW, Han J, Guthmiller JJ, Bailey MJ, et al
    Influenza hemagglutinin-specific IgA Fc-effector functionality is restricted to stalk epitopes.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
51. BURTON DR
    A new lease on life for an HIV-neutralizing antibody class and vaccine target.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    
    
    
    
52. SIT B, Fakoya B, Zhang T, Billings G, et al
    Dissecting serotype-specific contributions to live oral cholera vaccine efficacy.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
53. ZHANG H, You X, Wang X, Cui L, et al
    Delivery of mRNA vaccine with a lipid-like material potentiates antitumor efficacy through Toll-like receptor 4 signaling.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
54. MURAKOWSKI DK, Barton JP, Peter L, Chandrashekar A, et al
    Adenovirus-vectored vaccine containing multidimensionally conserved parts of the HIV proteome is immunogenic in rhesus macaques.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    January 2021
55. HANNA CC, Ashhurst AS, Quan D, Maxwell JWC, et al
    Synthetic protein conjugate vaccines provide protection against Mycobacterium tuberculosis in mice.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
56. RAPPUOLI R, De Gregorio E, Del Giudice G, Phogat S, et al
    Vaccinology in the post-COVID-19 era.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
57. PERSSON BD, John L, Rafie K, Strebl M, et al
    Human species D adenovirus hexon capsid protein mediates cell entry through a direct interaction with CD46.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
58. GUEST JD, Wang R, Elkholy KH, Chagas A, et al
    Design of a native-like secreted form of the hepatitis C virus E1E2 heterodimer.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
59. SU H, Liu Q, Bian X, Wang S, et al
    Synthesis and delivery of Streptococcus pneumoniae capsular polysaccharides by recombinant attenuated Salmonella vaccines.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
60. JUNG H, Albarracin D
    Concerns for others increases the likelihood of vaccination against influenza and COVID-19 more in sparsely rather than densely populated areas.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    December 2020
61. BOZHANOVA NG, Sangha AK, Sevy AM, Gilchuk P, et al
    Discovery of Marburg virus neutralizing antibodies from virus-naive human antibody repertoires using large-scale structural predictions.
    Proc Natl Acad Sci U S A. 2020;117:31142-31148.
    PubMed     Abstract available
    
    
    November 2020
62. HORNER C, Schurmann C, Auste A, Ebenig A, et al
    A highly immunogenic and effective measles virus-based Th1-biased COVID-19 vaccine.
    Proc Natl Acad Sci U S A. 2020 Nov 30. pii: 2014468117.
    PubMed     Abstract available
    
    
    
63. LI W, Chen C, Drelich A, Martinez DR, et al
    Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection.
    Proc Natl Acad Sci U S A. 2020;117:29832-29838.
    PubMed     Abstract available
    
    
    
64. HENRIQUES P, Dello Iacono L, Gimeno A, Biolchi A, et al
    Structure of a protective epitope reveals the importance of acetylation of Neisseria meningitidis serogroup A capsular polysaccharide.
    Proc Natl Acad Sci U S A. 2020;117:29795-29802.
    PubMed     Abstract available
    
    
    
65. GILBERT M, Sulikhan N, Uphyrkina O, Goncharuk M, et al
    Distemper, extinction, and vaccination of the Amur tiger.
    Proc Natl Acad Sci U S A. 2020 Nov 23. pii: 2000153117.
    PubMed     Abstract available
    
    
    
66. MASTERS NB, Eisenberg MC, Delamater PL, Kay M, et al
    Fine-scale spatial clustering of measles nonvaccination that increases outbreak potential is obscured by aggregated reporting data.
    Proc Natl Acad Sci U S A. 2020;117:28506-28514.
    PubMed     Abstract available
    
    
    
67. DATTA R, Roy Chowdhury R, Manjunath K, Hanna LE, et al
    A facile method of mapping HIV-1 neutralizing epitopes using chemically masked cysteines and deep sequencing.
    Proc Natl Acad Sci U S A. 2020 Nov 9. pii: 2010256117.
    PubMed     Abstract available
    
    
    October 2020
68. KAHN JP, Henry LM, Mastroianni AC, Chen WH, et al
    Opinion: For now, it's unethical to use human challenge studies for SARS-CoV-2 vaccine development.
    Proc Natl Acad Sci U S A. 2020 Oct 29. pii: 2021189117.
    PubMed    
    
    
    
69. CHENG Q, Trangucci R, Nelson KN, Fu W, et al
    Prenatal and early-life exposure to the Great Chinese Famine increased the risk of tuberculosis in adulthood across two generations.
    Proc Natl Acad Sci U S A. 2020 Oct 19. pii: 2008336117.
    PubMed     Abstract available
    
    
    
70. AFFANDI AJ, Grabowska J, Olesek K, Lopez Venegas M, et al
    Selective tumor antigen vaccine delivery to human CD169(+) antigen-presenting cells using ganglioside-liposomes.
    Proc Natl Acad Sci U S A. 2020 Oct 16. pii: 2006186117.
    PubMed     Abstract available
    
    
    
71. 
    Correction for Escobar et al., BCG vaccine protection from severe coronavirus disease 2019 (COVID-19).
    Proc Natl Acad Sci U S A. 2020 Oct 12. pii: 2019438117.
    PubMed    
    
    
    September 2020
72. LINDESTAM ARLEHAMN CS, Sette A, Peters B
    Lack of evidence for BCG vaccine protection from severe COVID-19.
    Proc Natl Acad Sci U S A. 2020 Sep 29. pii: 2016733117.
    PubMed    
    
    
    
73. PATELLA V, Delfino G, Bruzzese D, Giuliano A, et al
    The bacillus Calmette-Guerin vaccination allows the innate immune system to provide protection from severe COVID-19 infection.
    Proc Natl Acad Sci U S A. 2020 Sep 29. pii: 2015234117.
    PubMed    
    
    
    
74. BARILLAS-MURY C, Escobar LE, Molina-Cruz A
    Reply to Patella et al. and Lindestam Arlehamn et al.: Complex pandemic dynamics and effect of bacillus Calmette-Guerin (BCG) vaccination on COVID-19 prevalence and mortality.
    Proc Natl Acad Sci U S A. 2020 Sep 29. pii: 2017197117.
    PubMed    
    
    
    
75. METRAS R, Edmunds WJ, Youssouffi C, Dommergues L, et al
    Estimation of Rift Valley fever virus spillover to humans during the Mayotte 2018-2019 epidemic.
    Proc Natl Acad Sci U S A. 2020;117:24567-24574.
    PubMed     Abstract available
    
    
    
76. RAUSCH JW, Capoferri AA, Katusiime MG, Patro SC, et al
    Low genetic diversity may be an Achilles heel of SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2020 Sep 21. pii: 2017726117.
    PubMed    
    
    
    
77. HUANG D, Abbott RK, Havenar-Daughton C, Skog PD, et al
    B cells expressing authentic naive human VRC01-class BCRs can be recruited to germinal centers and affinity mature in multiple independent mouse models.
    Proc Natl Acad Sci U S A. 2020 Sep 1. pii: 2004489117.
    PubMed     Abstract available
    
    
    August 2020
78. SATHKUMARA HD, Muruganandah V, Cooper MM, Field MA, et al
    Mucosal delivery of ESX-1-expressing BCG strains provides superior immunity against tuberculosis in murine type 2 diabetes.
    Proc Natl Acad Sci U S A. 2020 Aug 10. pii: 2003235117.
    PubMed     Abstract available
    
    
    
79. ANTONELLI AC, Binyamin A, Hohl TM, Glickman MS, et al
    Bacterial immunotherapy for cancer induces CD4-dependent tumor-specific immunity through tumor-intrinsic interferon-gamma signaling.
    Proc Natl Acad Sci U S A. 2020;117:18627-18637.
    PubMed     Abstract available
    
    
    
80. PAPADOPOULOU M, Dimova T, Shey M, Briel L, et al
    Fetal public Vgamma9Vdelta2 T cells expand and gain potent cytotoxic functions early after birth.
    Proc Natl Acad Sci U S A. 2020;117:18638-18648.
    PubMed     Abstract available
    
    
    
81. SPRENGER KG, Louveau JE, Murugan PM, Chakraborty AK, et al
    Optimizing immunization protocols to elicit broadly neutralizing antibodies.
    Proc Natl Acad Sci U S A. 2020 Aug 3. pii: 1919329117.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: